RecruitingNot ApplicableNCT06296550

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes

Sponsor

Scripps Whittier Diabetes Institute

Enrollment

140 participants

Start Date

Apr 3, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetes Type 2

Summary

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether pairing an online diabetes education program with a continuous glucose monitor (a small wearable sensor that tracks blood sugar in real time) leads to better blood sugar control in people with type 2 diabetes. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - Your HbA1c (a 3-month blood sugar average) is between 7.5% and 12.0% - You are not currently using a continuous glucose monitor (CGM) - You do not use insulin - You speak English, Spanish, or Arabic - You have a cell phone that can send/receive texts and count steps **You may NOT be eligible if...** - You use insulin therapy - You are pregnant - You already use a CGM - You are currently enrolled in another diabetes study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDulce Digital Text Messaging Intervention

Text-based education support program: * Participants will receive text messages about diabetes and how to take care of diabetes and health. Participants will receive 2-3 messages every day for first 3 months, and then will slowly decrease over the last 3-months. * Participants will also receive text messages that will ask them to test their blood sugar and text back blood sugar reading.

OTHERCGM Device

Participants will be provided continuous glucose monitors (Dexcom G7) to actively monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months). In addition, participants will attend an information session (group or individual; in-person or virtual) that will provide instructions on using continuous glucose monitors.

Locations(1)

Scripps Whittier Diabetes Institute

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06296550

Related Trials

Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes

NCT071767931 location

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

NCT074850752 locations

Disentangling the Effect of Brain Insulin Resistance on Brain Health

NCT073747053 locations

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

NCT059126471 location

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

NCT073506941 location